ABT : Analysis & Opinions

  1. Abbott Labs Stock Trades Ex-Dividend Wednesday

    January 10, 2017
    Abbott Labs will send its dividend payment on Feb. 15 to shareholders of record as of Jan. 13.
  2. Abbott Sets Closing Date for St. Jude Medical Deal

    December 31, 2016
    Abbott Laboratories (NYSE: ABT) will enter the new year a larger company. It anticipates closing its latest acquisition ...
  3. Most Important Mergers and Acquisitions of 2016

    December 27, 2016
    While 2016 did not see a $100 billion deal, there were plenty of important multibillion-dollar deals.
  4. St. Jude's $25B Merger with Abbott OKed (STJ, ABT)

    October 27, 2016
    St. Jude Medical shareholders approved the company's $25 billion merger with Abbott Laboratories.
  5. Abbott, St. Jude Divests $1B in Assets (ABT, STJ)

    October 20, 2016
    Abbott and St. Jude Medical, which are merging, will sell a portion of their vascular closure and electrophysiology businesses ...
  6. Drug Wars: California Vote Could Limit Price Hikes

    October 19, 2016
    Major drug companies have spent $60 million to defeat a referendum calling for price limits
  7. Does a Clinton Victory Scare the Biotech Sector? (AMGN, ILMN)

    October 13, 2016
    Biotech stocks face further turmoil if the Democrats win control of Congress and move to rein in prices for new drugs
  8. Celgene, Agios, Abbott Team For Test (CELG, AGIO)

    October 12, 2016
    Celgene and Agios will collaborate with Abbott Laboratories to develop a diagnostic test for leukemia using Abbott's proprietary ...
  9. St. Jude Medical Shares Fall Amid Device Failure (STJ, ABT)

    October 12, 2016
    Amid reports of two deaths owing to STJ device battery failure, the company lost around 4% of valuation.
  10. J&J Buys Abbott's Eye Health Unit for $4.3 Billion

    September 19, 2016
    Johnson & Johnson (NYSE: JNJ) has obviously been keeping its eyes peeled for  big-time acquisitions: The company just ...
  11. Will the Strong Dollar Hurt Abbott's Q2 Earnings?

    July 19, 2016
    The Abbott Park, IL.-based company has made global expansion an important aspect of its future growth. But will the strong ...
  12. How Biotech Companies Expecting M&A Deals Can Offer High Returns ...

    May 17, 2016
    With a 35% decline, consolidation appears imminent in the biotech sector. Here are the potential M&A candidates and how to ...
  13. Dividend Payout vs. Dividend Growth: Which Ratio Should You Prefer? ...

    May 3, 2016
    Learn why growth investors should focus on dividend payouts, and which large-company stocks are capable of sustaining earnings ...
  14. Abbott to Buy St. Jude Medical for $25 Billion

    April 29, 2016
    Acquisitive pharmaceutical major Abbott Laboratories is adding another new asset to its portfolio. The company has agreed ...
  15. (VRX) Who are Valeant's Main Competitors?

    April 23, 2016
    Learn which companies Valeant is likely watching closely, since it is known for acquiring companies for their products rather ...
  16. Valeant vs. Abbott Labs: Which Is Better for My Portfolio? (VRX, ...

    April 16, 2016
    Explore the differences between Abbott Laboratories and Valeant Pharmaceuticals, as well as which stock is the best addition ...
  17. Health Care ETFs to Date: 2016 Performance Review (IHI, XBI)

    April 2, 2016
    Find out how the health care sector has been performing in 2016, and which health care ETFs have been the best and worst ...
  18. The World's Top 10 Health Care Companies (UNH, MDT)

    March 9, 2016
    Discover the world's top 10 health care companies according to market capitalization, including a brief summary of each.
  19. The Top 10 Healthcare Stocks for 2016 (ABT, AGN)

    January 6, 2016
    Learn about the top 10 health care stocks expected to grow in 2016, with brief insights into each company's growth potential ...
  20. Is Eli Lilly Now a Solid Income Investor Play?

    December 10, 2015
    Pharmaceutical giant Eli Lilly (NYSE: LLY) has declared a fresh dividend raise, albeit an incremental one. The company has ...
  21. The 8 Top Business Incubators (CAT, YHOO)

    September 28, 2015
    Business incubators can play a crucial role in the life of a start-up. Here's our list of the top eight incubators
  22. Worried About a Recession? Then Buy These 5 Stocks

    April 10, 2015
    What makes these stocks so resilient? And how did they perform during the last crisis?
  23. How is a Spinoff Worth $100 Billion? See AbbVie

    April 1, 2015
    An in depth look at Abbott Labs spinoff AbbVie and how it became a nearly $100 billion company.
  24. The Future of Big Pharma Stocks

    March 31, 2015
    A look at the future health of big pharma stocks.
  25. Interested In Pharmaceutical Stocks? Try Novartis (ADR)

    February 26, 2015
    Novartis AG, is the world's leading pharmaceutical company by sales. Here is a closer look at Novartis, and how its financials ...
  26. Your Best Bet for Healthcare Stocks: The XHE ETF

    January 20, 2015
    With the decent growth and wide profit margins of medical device companies, the XHE ETF shouldn't be ignored.
  27. The Cyprus Crisis 101

    March 19, 2013
    Discover what's behind the Cyprus debacle and what investors should do about the situation.
  28. Abbott Labs Spins Off AbbVie: Which Is The Better Buy?

    January 4, 2013
    January 2 was the first day of trading for the pharmaceutical spin-off.
  29. Bio-Reference Labs Taking Advantage Of Esoteric Opportunities

    June 22, 2012
    The decision of whether to buy Bio-Reference really comes down to an investor's confidence in the growth prospects for the ...
  30. Nestle Almost Never On Sale

    April 24, 2012
    Nestle has a well-earned reputation for excellence and the Street has long been happy to pay a premium for that performance. ...
  31. 4 Stocks To Contemplate Before Wednesday

    January 24, 2012
    Here are four companies that will be releasing their earnings on January 25th.
  32. Covidien Delivers Once Again

    November 21, 2011
    Covidien is overlooked and undervalued.
  33. Will Nestle Succeed Where Others Have Failed?

    May 26, 2011
    Nestle is making an interesting step into medical pharmaceuticals and diagnostics.
  34. Danaher Hopes To Revive Beckman Coulter

    February 9, 2011
    Learn more about Danaher's expensive, albeit strategic, bid for a leading diagnostics franchise.
  35. Biotech Stocks Ready Ready To Break Out

    September 7, 2010
    Biotech Stocks Ready Ready To Break Out
  36. Abbott Labs Shows Textbook Case For Turnaround

    October 9, 2008
    ABT is nearing a long-term support level, which could prop up the price of the shares.
  37. Who's Really Winning The Heart-Stent Race?

    May 14, 2008
    All the stent makers claim they're the sole industry leader. We help cut through the clutter.